Blair William & CO Selecta Biosciences Inc Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$1.23 - $3.31 $12,377 - $33,308	10,063 Added 67.31%	25,013 $31,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $43,205 - $66,228	14,950 New	14,950 $49,000
Q2 2020 Aug 12, 2020	SELL	$1.83 - $4.06 $36,600 - $81,199	-20,000 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$1.5 - $4.52 $30,000 - $90,399	20,000 New	20,000 $48,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.